A Study of the Safety, Tolerability and Effectiveness of Hydroxychloroquine and Itraconazole in Platinum-resistant Epithelial Ovarian Cancer
Clinical trial NCT03081702 · COMPLETED
Trial details
- NCT number
- NCT03081702
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-25
- Primary completion
- 2019-08-27
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.